Page last updated: 2024-08-25

gr 117289 and Goldblatt Syndrome

gr 117289 has been researched along with Goldblatt Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Drew, GM; Gardner, CJ; Hilditch, A; Hunt, AA; Middlemiss, D; Polley, J; Robertson, MJ; Ross, BC; Travers, A; Twissell, DJ1

Other Studies

1 other study(ies) available for gr 117289 and Goldblatt Syndrome

ArticleYear
Cardiovascular effects of GR117289, a novel angiotensin AT1 receptor antagonist.
    British journal of pharmacology, 1994, Volume: 111, Issue:1

    Topics: Administration, Oral; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Callithrix; Dogs; Dose-Response Relationship, Drug; Hypertension; Hypertension, Renovascular; Injections, Intra-Arterial; Male; Nicotinic Acids; Rats; Rats, Inbred SHR; Tetrazoles

1994